RANDOMIZED, CONTROLLED TRIAL OF A 10-DAY COURSE OF AMIFLOXACIN VERSUS TRIMETHOPRIM-SULFAMETHOXAZOLE IN THE TREATMENT OF ACUTE, UNCOMPLICATED URINARY-TRACT INFECTION

被引：11

作者：

BOYKO, EJ

IRAVANI, A

SILVERMAN, MH

SCHELLING, DJ

WRIGHT, RA

机构：

[1] STERLING DRUG INC,RENSSELAER,NY 12144

[2] EASTSIDE NEIGHBORHOOD HLTH CTR,DENVER,CO 80205

[3] UNIV COLORADO,HLTH SCI CTR,DENVER,CO 80262

[4] UNIV FLORIDA,COLL MED,GAINESVILLE,FL 32610

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1990年 / 34卷 / 04期

关键词：

D O I：

10.1128/AAC.34.4.665

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We conducted a randomized controlled trial of orally administered amifloxacin versus trimethoprim-sulfamethoxazole (TMP-SMX) as treatments of acute uncomplicated urinary tract infection in women. Amifloxacin at a dosage of 200 mg twice a day appeared as safe and effective as TMP-SMX, but amifloxacin at 400 mg twice a day tended to cause adverse events more frequently than did TMP-SMX.

引用

页码：665 / 667

页数：3

共 9 条

[1] COMPARATIVE ANTIMICROBIAL ACTIVITY OF ENOXACIN, CIPROFLOXACIN, AMIFLOXACIN, NORFLOXACIN AND OFLOXACIN AGAINST 177 BACTERIAL ISOLATES [J].